$MSFT Climbs Again: Can Biotech Outpace Big Tech?Microsoft ($MSFT) rose on AI investments—long-term, it’s a safe hold. But diagnostic biotech has explosive potential. MYNZ’s sector is producing breakthroughs that could redefine healthcare, with growth still in early stages.